What's New

On December 5th, SNBL seminar was held in Seoul, South Korea.

On December 5th, SNBL seminar was held in Seoul, South Korea.

2024/02/13

Ina Research gave a talk on our services there. Many participants listened to our speech with great enthusiasm and asked many questions. The seminar was featured in the Korean news of Dairy Medi.

INA’s response to the spread of COVID-19 (SARS-CoV-2) Novel Coronavirus infections in Japan

INA’s response to the spread of COVID-19 (SARS-CoV-2) Novel Coronavirus infections in Japan

2020/03/25

With the health safety and security of all stakeholders including employees and customers as our top priority, Ina Research (INA) has been implementing measures based on guidance received from government authorities in order to help prevent the spread of COVID-19 (SARS-CoV-2) infections. COVID-19 is the most urgent social concern in the world. However, comparing with European countries and US or China, the COVID-19 infection overshoot has not appeared in Japan as of today (March 25, 2020). Needless to say, we are never off our guard and protection to maintain all contracted studies in operation and all future studies. Animal Rooms: We, INA has highly advanced technologies such as One-by-One Animal

Information about entering into an agency contract with SAGE HEALTHCARE PTE LTD.

Information about entering into an agency contract with SAGE HEALTHCARE PTE LTD.

2019/12/03

Ina Research Co., Ltd. (hereinafter “the Company”) has decided today to enter into an agency contract with SAGE HEALTHCARE PTE LTD (hereinafter “SAGE”) in Singapore for the purpose of expanding sales of non-clinical studies focusing on pharmaceuticals. Information about entering into an agency contract with SAGE HEALTHCARE PTE LTD. – PDF (132KB)

Services